Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053189 | SCV001217436 | benign | Autosomal dominant nonsyndromic hearing loss 1; Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome | 2024-08-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004977935 | SCV005566368 | uncertain significance | Inborn genetic diseases | 2024-07-17 | criteria provided, single submitter | clinical testing | The c.65G>A (p.S22N) alteration is located in exon 1 (coding exon 1) of the DIAPH1 gene. This alteration results from a G to A substitution at nucleotide position 65, causing the serine (S) at amino acid position 22 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |